ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HILS Hillstream BioPharma Inc

0.2305
0.00 (0.00%)
Apr 18 2024 - Closed
Delayed by 15 minutes

Hillstream BioPharma Financial Summary

The current HILS market cap is 4.04M. The company's latest EPS is USD -0.5321 and P/E is -0.71.

Quarter End Mar 2022Sep 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -1.35M-2.13M-2.72M-2.36M-1.85M
Net Income -2.94M-2.13M-2.69M-2.34M-1.82M
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000
Operating Income -2.17B-3.21M-6.88M-9.46M
Net Income -2.42B-2.21M-8.47M-9.32M
Quarter End Mar 2022Sep 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)
Total Assets 11.36M7.83M4.72M4.6M3.17M
Total Liabilities 1.02M717k1.52M1.53M1.41M
Total Equity 10.34M7.12M3.2M3.07M1.76M
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Assets 294.8M622k6.69M10.95M
Total Liabilities 4.01B5.31M1.15M1.82M
Total Equity -3.72B-4.69M5.54M9.13M
Quarter End Mar 2022Sep 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)
Operating -2.01M-5.49M-3.47M-4.98M-5.89M
Investing N/A N/A N/A N/A N/A
Financing 13.13M13.09M523k2.37M2.06M
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Operating -1.08B-1.09M-6.56M-7.3M
Investing N/A N/A N/A N/A
Financing 1.23B899k13.06M11.72M
Market Cap 4.04M
Price to Earnings Ratio -0.71
Price to Sales Ratio 0
Price to Cash Ratio 0.61
Price to Book Ratio 0.73
Dividend Yield -

Share Statistics

Shares Outstanding 17.51M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -74.51%
52 Week High 1.26
52 Week Low 0.1903
Spread (Intraday) 0.01 (3.96%)

Company Info

Company Name Hillstream BioPharma Inc
Address 16192 coastal hwy
lewes, delaware 19958
Website https://www.hillstreambio.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock